Vimarsana
Biggest News Aggregation in the World

Page 2 - Aptose Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptose Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptose Bioscience Today - Breaking & Trending Today

Brokers Set Expectations for Aptose Biosciences Inc.'s FY2023 Earnings (NASDAQ:APTO) - Vimarsana News

Brokers Set Expectations for Aptose Biosciences Inc.'s FY2023 Earnings (NASDAQ:APTO)

Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Equities research analysts at Cantor Fitzgerald reduced their FY2023 earnings per share estimates for shares of Aptose Biosciences in a report issued on Tuesday, May 9th. Cantor Fitzgerald analyst L. Watsek now forecasts that the biotechnology company will post earnings of ($0.42) per share for the […]

Contrasting Aptose Biosciences (NASDAQ:APTO) and Quince Therapeutics (NASDAQ:QNCX) - Vimarsana News

Contrasting Aptose Biosciences (NASDAQ:APTO) and Quince Therapeutics (NASDAQ:QNCX)

Aptose Biosciences (NASDAQ:APTO – Get Rating) and Quince Therapeutics (NASDAQ:QNCX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability. Analyst Recommendations This is a breakdown of recent ratings […]

Reviewing Quince Therapeutics (NASDAQ:QNCX) and Aptose Biosciences (NASDAQ:APTO) - Vimarsana News

Reviewing Quince Therapeutics (NASDAQ:QNCX) and Aptose Biosciences (NASDAQ:APTO)

Aptose Biosciences (NASDAQ:APTO – Get Rating) and Quince Therapeutics (NASDAQ:QNCX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Volatility and Risk Aptose Biosciences has a beta of […]

Aptose Biosciences Inc. Expected to Earn FY2022 Earnings of ($0.60) Per Share (TSE:APS) - Vimarsana News

Aptose Biosciences Inc. Expected to Earn FY2022 Earnings of ($0.60) Per Share (TSE:APS)

Aptose Biosciences Inc. (TSE:APS – Get Rating) (NASDAQ:APTO) – Cantor Fitzgerald issued their FY2022 earnings estimates for Aptose Biosciences in a note issued to investors on Wednesday, September 21st. Cantor Fitzgerald analyst L. Watsek forecasts that the biotechnology company will post earnings per share of ($0.60) for the year. Cantor Fitzgerald currently has a “Overweight” […]

FY2022 Earnings Estimate for Aptose Biosciences Inc. Issued By Cantor Fitzgerald (NASDAQ:APTO) - Vimarsana News

FY2022 Earnings Estimate for Aptose Biosciences Inc. Issued By Cantor Fitzgerald (NASDAQ:APTO)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.